Miola, Alessandro
Gardea-Reséndez, Manuel
Ortiz-Orendain, Javier
Nunez, Nicolas A.
Ercis, Mete
Coombes, Brandon J.
Salgado, Manuel Fuentes
Gruhlke, Peggy M.
Michel, Ian
Bostwick, J. Michael
McKean, Alastair J.
Ozerdem, Aysegul
Frye, Mark A.
Funding for this research was provided by:
Mayo Foundation for Medical Education and Research
Assurex Health
Article History
Received: 10 May 2023
Accepted: 8 November 2023
First Online: 8 December 2023
Declarations
:
: The current retrospective population-based study was approved by the institutional review boards (IRBs) of Mayo Clinic (IRB # 20–006720 and 20–008773) and Olmsted Medical Center (Approval dates: 11/20/2020 and 04/22/2021) who provided a Health Insurance Portability and Accountability Act (HIPAA) waiver, in line with state, federal, and international recommendations. Hence, written informed consent was not required for passive medical record review in the REP.
: Mark A. Frye received grant support from Assurex Health and Mayo Foundation, received CME travel and honoraria from Carnot Laboratories, and has Financial Interest/Stock ownership/Royalties from Chymia LLC. No other declaration of interests from other authors.